Table 2.

Correlation between FENDRR, miR-214-3p, TET2 expression level and clinicopathological parameters

Clinicopathological parameters	N	FENDRR expression			P value	miR-214-3p expression			P value	TET2 expression			P value
		Low	High	Positive rate		Low	High	Positive rate		Low	High	Positive rate
Gender
Male	59	29	30	50.85%	0.067	23	36	61.02%	0.5384	32	27	45.76%	0.2287
Female	41	28	13	31.71%		19	22	53.66%		17	24	58.54%
Age (years)
≥ 50	54	28	26	48.15%	0.154	39	15	27.78%	0.6644	27	27	50.00%	1.000
< 50	46	31	15	32.61%		31	15	32.61%		23	23	50.00%
TNM stage
I/II	63	35	40	63.49%	0.045	32	31	49.21%	0.0117	34	29	46.03%	0.035
III/IV	37	28	9	24.32%		9	28	75.68%		28	9	24.32%
Lymph node metastasis
YES	65	23	42	64.62%	0.0214	18	47	72.31%	0.0283	47	18	27.69%	0.0103
NO	35	21	14	40.00%		18	17	48.57%		16	19	54.29%